Pfizer on Friday reported 22.83 per cent increase in net profit at Rs 112.81 crore for the quarter ended June 30, 2019.
The company had posted a profit of Rs 91.84 crore in the same quarter last fiscal, Pfizer said in a regulatory filing.
Total income during the quarter under review stood at Rs 580.23 crore as against Rs 542.84 crore in the corresponding quarter last fiscal, it added.
Total expenses during the first quarter were marginally higher at Rs 405.32 crore as compared to 400.65 crore in the year-ago period, it added.
Pfizer said it has received approval from Maharashtra Industrial Development Corporation (MIDC) in July for transfer of its business undertaking at Thane, including land, plant, machinery and employees except for a certain portion of land, following sale to Vidhi Research & Development LLP.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app